₹6,020.50 146.55 (2.49%)
04:01 PM, 30-Dec-2024₹6,045.00 163.95 (2.79%)
03:52 PM, 30-Dec-2024BSE : 532488
NSE : DIVISLAB
Sector : Health care
ISIN Code : INE361B01024
Last Updated: 30-Dec-2024 | 09:31 PM IST
Market Cap (₹ Cr.) | 1,59,814 |
Traded Value (₹ Cr) | 28.20 |
Volume (Shares) | 46,833 |
Face Value (₹) | 2 |
52-Week High (₹) | 6,448.75 |
52-Week High Date | 02-Dec-2024 |
52-Week Low (₹) | 3,350.05 |
52-Week Low Date | 27-Mar-2024 |
All Time High (₹) | 6,448.75 |
All Time High Date | 02-Dec-2024 |
All Time Low (₹) | 7.70 |
All Time Low Date | 12-Mar-2003 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr.) | 1,60,465 |
EPS - TTM (₹) [C] | 69.16 |
P/E Ratio (X) [C] | 87.41 |
Face Value (₹) | 2 |
Latest Dividend (%) | 1,500.00 |
Latest Dividend Date | 02-Aug-2024 |
Dividend Yield (%) | 0.49 |
Book Value Share (₹) [C] | 516.71 |
P/B Ratio (₹) [C] | 11.70 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Canara Robeco Equity Hybrid Fund (IDCW-M) | 114.60 | 1,95,000 | 1.03 |
Canara Robeco Equity Hybrid Fund - Direct (G) | 114.60 | 1,95,000 | 1.03 |
Canara Robeco Equity Hybrid Fund - Direct (IDCW-M) | 114.60 | 1,95,000 | 1.03 |
Canara Robeco Equity Hybrid Fund (G) | 114.60 | 1,95,000 | 1.03 |
Canara Robeco Balanced Advantage Fund - Dir (IDCW) | 13.60 | 23,150 | 0.89 |
Canara Robeco Balanced Advantage Fund - Dir (G) | 13.60 | 23,150 | 0.89 |
Canara Robeco Balanced Advantage Fund - Reg (IDCW) | 13.60 | 23,150 | 0.89 |
Canara Robeco Balanced Advantage Fund - Reg (G) | 13.60 | 23,150 | 0.89 |
360 ONE Balanced Hybrid Fund - Regular (IDCW) | 10.23 | 17,407 | 1.17 |
360 ONE Balanced Hybrid Fund - Regular (G) | 10.23 | 17,407 | 1.17 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
10-Nov-2024 | Motilal Oswal | Neutral | 5,630 | |
04-Aug-2024 | ICICI Securities | Sell | 3,670 | |
26-May-2024 | Motilal Oswal | Neutral | 3,900 | |
05-Feb-2023 | ICICI Direct | Hold | 2,945 |
Today's Low/High (₹) | 5,880.00 6,138.85 |
Week Low/High (₹) | 5,716.50 6,138.85 |
Month Low/High (₹) | 5,716.50 6,285.00 |
Year Low/High (₹) | 3,350.00 6,285.00 |
All time Low/High (₹) | 7.70 6,285.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 3.36% | 3.34% | -0.37 | -0.46% |
1 Month | -2.04% | -2.07% | -1.95 | -2.01% |
3 Month | 10.99% | 11.05% | -7.18 | -8.39% |
6 Month | 31.55% | 31.51% | -0.99 | -1.52% |
1 Year | 54.93% | 54.85% | 8.32 | 8.81% |
3 Year | 30.64% | 30.62% | 35.39 | 37.44% |
Chairman & Managing Director : Murali K Divi
Executive Director : N V Ramana
Whole Time Director & CEO : Kiran S Divi
Independent Director : K V K Seshavataram
Chairman & Independent Directo : Ramesh B V Nimmagadda
Whole Time Director -Commercia : Nilima Motaparti
Independent Director : S Ganapaty
Independent Director : Sunaina Singh
Independent Director : Kosaraju Veerayya Chowdary
Company Sec. & Compli. Officer : Satish Choudhury
Whole-time Director : S. Devendra Rao
Independent Director : Rajendrakumar Premchand Shah
Registered Office: 1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli,Hyderabad,Telangana-500032 Ph: 91-40-23786300/23786352/400
1. What's the Divis Laboratories Ltd share price today?
Divis Laboratories Ltd share price was Rs 6,020.50 at 04:01 PM IST on 30th Dec 2024. Divis Laboratories Ltd share price was up by 2.49% over the previous closing price of Rs 5,873.95. Divis Laboratories Ltd share price trend:
2. How can I quickly analyse the performance of the Divis Laboratories Ltd stock?
The performance of the Divis Laboratories Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Divis Laboratories Ltd?
Divis Laboratories Ltd has a market capitalisation of Rs 1,59,814 crore.
4. What is Divis Laboratories Ltd's 52-week high/low share price?
The Divis Laboratories Ltd’s 52-week high share price is Rs 6,448.75 and 52-week low share price is Rs 3,350.05.
5. Is the Divis Laboratories Ltd profitable?
On a consolidated basis, Divis Laboratories Ltd reported a profit of Rs 518.00 crore on a total income of Rs 2,407.00 crore for the quarter ended 2024. For the year ended Sep 2024, Divis Laboratories Ltd had posted a profit of Rs 510.00 crore on a total income of Rs 2,444.00 crore.
6. Which are Divis Laboratories Ltd’s peers in the Health care sector?
Divis Laboratories Ltd’s top 5 peers in the Health care sector are Sun Pharma.Inds., Divi's Lab., Cipla, Mankind Pharma, Dr Reddy's Labs.
7. Who owns how much in Divis Laboratories Ltd?
Key changes to the Divis Laboratories Ltd shareholding are as follows: